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The dissociated form of kappa-casein is the precursor to its amyloid fibril
formation
Abstract
Bovine milk kappa-casein forms a self-associating oligomeric micelle-like species, in equilibrium with
dissociated forms. In its native form, intra- and inter-molecular disulfide bonds lead to the formation of
multimeric species ranging from monomers to decamers. When incubated under conditions of
physiological pH and temperature, both reduced and non-reduced kappa-casein form highly structured
beta-sheet amyloid fibrils. We investigated whether the precursor to kappa-casein fibril formation is a
dissociated state of the protein or its oligomeric micelle-like form. We show that reduced kappa-casein is
capable of forming fibrils well below its critical micelle concentration, i.e. at concentrations where only
dissociated forms of the protein are present. Moreover, by regulating the degree of disulfide linkages, we
were able to investigate how oligomerization of kappa-casein influences its propensity for fibril formation
under conditions of physiological pH and temperature. Thus, using fractions containing different
proportions of multimeric species, we demonstrate that the propensity of the disulfide-linked multimers to
form fibrils is inversely related to their size, with monomeric kappa-casein being the most aggregation
prone. We conclude that dissociated forms of kappa-casein are the amyloidogenic precursors to fibril
formation rather than oligomeric micelle-like species. The results highlight the role of oligomerization and
natural binding, partners in preventing amyloid fibril formation by disease-related proteins in vivo.
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The dissociated form of κ-casein is the precursor to its amyloid fibril
formation
Heath ECROYD*†1,2 , David C. THORN†1 , Yanqin LIU† and John A. CARVER†

Bovine milk κ-casein forms a self-associating oligomeric micellelike species, in equilibrium with dissociated forms. In its native
form, intra- and inter-molecular disulfide bonds lead to the
formation of multimeric species ranging from monomers to
decamers. When incubated under conditions of physiological
pH and temperature, both reduced and non-reduced κ-casein
form highly structured β-sheet amyloid fibrils. We investigated
whether the precursor to κ-casein fibril formation is a dissociated
state of the protein or its oligomeric micelle-like form. We show
that reduced κ-casein is capable of forming fibrils well below
its critical micelle concentration, i.e. at concentrations where
only dissociated forms of the protein are present. Moreover,
by regulating the degree of disulfide linkages, we were able
to investigate how oligomerization of κ-casein influences its

propensity for fibril formation under conditions of physiological
pH and temperature. Thus, using fractions containing different
proportions of multimeric species, we demonstrate that the
propensity of the disulfide-linked multimers to form fibrils is
inversely related to their size, with monomeric κ-casein being the
most aggregation prone. We conclude that dissociated forms of κcasein are the amyloidogenic precursors to fibril formation rather
than oligomeric micelle-like species. The results highlight the
role of oligomerization and natural binding partners in preventing
amyloid fibril formation by disease-related proteins in vivo.

INTRODUCTION

occurs through an alternative mechanism in which the ratelimiting step is the dissociation of an amyloidogenic species from
an oligomeric state [7]. This mechanism was based on the finding
that the lag phase of RCMκ-CN’s fibril formation is independent
of protein concentration and the rate of fibril formation does not
increase upon addition of seeds (pre-formed fibrils) [7]. Such a
mechanism may apply more broadly, e.g. to disease-related fibrilforming proteins, where the rate-limiting step to fibril formation
is the dissociation of a monomeric precursor from a binding
partner or multisubunit complex (e.g. transthyretin in systemic
amyloidosis) [8–10], or its formation through proteolytic cleavage
(e.g. amyloid β-peptides in Alzheimer’s disease) [5].
κ-CN (κ-casein) is a 169-amino-acid 19 kDa glycoprotein
that is one of the major casein proteins in milk micelles: the
others are α s1 -, α s2 - and β-casein. The caseins exhibit a strong
tendency to associate, both with themselves and each other,
through hydrophobic and electrostatic interactions, leading to the
formation of casein micelles [11]. κ-CN plays a critical role in
the stability and structure of these micelles, which, because of
the incorporation of Ca2+ and other ions, have a vital nutritional
role for the newborn. All of the caseins belong to the group
of ‘intrinsically disordered’ or ‘natively unfolded’ proteins as
they possess relatively little ordered structure under physiological
conditions [12,13]. As a consequence, no casein proteins have
been crystallized; however, three-dimensional energy-minimized
models are available [14–17]. With regard to κ-CN, spectroscopic
and molecular modelling studies indicate that the monomeric
form of the protein adopts a ‘horse and rider’ conformation
with persistent secondary-structural elements/motifs, the most
significant being two sets of antiparallel β-sheets which are rich

Recently, there has been an increase in the number of
diseases classified as amyloidoses, i.e. diseases with pathological
hallmarks that include intra- or extra-cellular deposits of amyloid
fibrils and/or amyloid plaques in tissues [1,2]. Amyloid fibrilrelated diseases include Alzheimer’s disease, Parkinson’s disease,
Type 2 diabetes and Huntington’s disease, and their incidence
will increase substantially in the future as the population ages.
Although there is still some debate over whether amyloid fibril
formation is causative of disease, it is certainly intimately linked
to disease progression, and the formation of fibrils, from both
disease-related and non-disease-related proteins, is toxic to cells
[3]. Thus investigations into the mechanism by which fibrils are
formed are critical in attempts to understand, and therefore treat,
such diseases.
Amyloid fibrils are an aggregated state of proteins that form
when partially folded intermediates mutually associate and enter
the off-folding pathway [1,2,4]. Their association is mediated
by β-strand motifs, and stacking of these β-strands is the basis
of fibril nucleation and elongation [5]. Since the β-strand is a
physiochemical property of the polypeptide backbone, rather than
of the type of amino acids, it has been proposed that the amyloid
fibril state is a generic conformation accessible to all polypeptide
chains, given the appropriate conditions [1,6]. Typically, fibril
formation is described by a nucleation-dependent mechanism in
which the rate-limiting step is the formation of the stable nucleus
(which corresponds to the lag phase) [5]. However, recently,
we proposed that fibril formation by RCMκ-CN (reduced and
carboxymethylated bovine κ-casein), a major protein in milk,
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in hydrophobic side chains [15]. Our work has shown that this
putative β-sheet region is incorporated into the core of fibrils
formed by κ-CN and probably provides the basis for its high
propensity for fibril formation [7].
We have also shown that native (non-reduced) bovine κ-CN
forms fibrils under conditions of physiological pH and
temperature [18] and have proposed that this process may account
for the proteinaceous deposits found within corpora amylacea
of mammary tissue which are amyloid in nature [19–21]. κ-CN
contains two cysteine residues and, in the native form of the
protein, intermolecular disulfide bonds lead to the formation
of multimers (ranging from dimers to decamers) [22], which
associate further, via electrostatic, hydrophobic and hydrogenbonding interactions, to form micelle-like oligomers of ∼ 18 nm
in diameter [23]. When completely reduced, κ-CN forms a selfassociating oligomeric species whose quaternary structure is
maintained by these electrostatic, hydrophobic and hydrogenbonding interactions. This oligomeric species has been likened
to a micelle in that the hydrophobic regions of κ-CN are largely
buried within the core of a spherical oligomer and are shielded
from solution by hydrophilic regions of the protein [24]. We
therefore define any oligomeric form of κ-CN resulting from noncovalent interactions as micelle-like in order to distinguish these
species from smaller oligomeric forms (e.g. dimers or trimers)
that are maintained by disulfide bonds. These latter forms we
refer to as dissociated forms.
Previous studies have suggested that, under reducing
conditions, the micelle-like species is in equilibrium with a
dissociated (monomeric) form [25]. As reduction of κ-CN
enhances its ability to form fibrils, we [7,18] and others
[26] have proposed that dissociated forms of the protein
(i.e. monomers and disulfide-linked dimers or trimers) are
the precursor to fibril formation. However, a recent study by
Leonil et al. [27] using glycosylated and non-glycosylated
forms of RCMκ-CN concluded that the micelle-like state of the
protein is the amyloidogenic precursor. In the present paper, we
describe experiments aimed at investigating this proposal further
by examining the fibril-forming propensity of RCMκ-CN at
concentrations below its CMC (critical micelle concentration),
i.e. at concentrations at which only dissociated forms of the
protein are present. In addition, we have conducted studies to
isolate various oligomeric forms present in the native and partially
reduced state of the protein in order to correlate their propensity
for fibril formation with their oligomeric state. Together, these
results show that oligomerization of κ-CN acts to suppress its
fibril formation and highlight the role of oligomerization and of
natural binding partners (i.e. α S - and β-casein) in inhibiting this
process in vivo.

Determination of the CMC of κ-CN

The CMC of RCMκ-CN and κ-CN reduced with 20 mM DTT
was determined using the Wilhelmy plate method, which is
based on a change in the relationship between surface tension
and concentration once the CMC has been reached. The surface
tension of solutions of RCMκ-CN and κ-CN reduced with 20 mM
DTT (in mN · m−1 ) was recorded at room temperature (25 ◦C) and
the results are representive of two independent experiments.
Preparation of RCMκ-CN and multimeric (partially reduced)
RCMκ-CN

For some of the experiments, κ-CN was fully reduced and
carboxymethylated as described previously [26,29]. Alternatively,
κ-CN was partially reduced by initially isolating large oligomeric κ-CN species. Thus whole native κ-CN (100 mg) in 50 ml
of 50 mM Tris/HCl and 8 M urea (pH 8.0) was concentrated to
5 ml over an ultrafiltration membrane with a 100 kDa molecularmass cut-off membrane. To ensure thorough filtration, the sample
was twice re-concentrated to 5 ml following the addition of two
sequential 50 ml volumes of the same buffer. The final concentrate
(i.e. κ-CN >100 kDa) was then subjected to the same reduction
and carboxymethylation process as for native κ-CN, which was
found to result in only partial reduction of the species present (see
the Results section). We refer to this preparation as multimeric
RCMκ-CN.
Fractionation of multimeric RCMκ-CN

Multimeric RCMκ-CN was separated into three major
components by SEC (size-exclusion chromatography) using
a Superdex-200 HR 10/30 column (GE Healthcare). Protein
(1.5 mg) was injected in 100 μl volumes, and eluted with 50 mM
ammonium acetate, 30 % (v/v) ACN (acetonitrile) (pH 7.2) at a
flow rate of 0.5 ml/min. To minimize protein degradation, one
tablet of EDTA-free protease inhibitor was added to 2 ml of
sample before injection. Additionally, every precaution was taken
to ensure the protein was kept at low temperature; the eluting
buffer and sample loop were chilled in ice, and the eluted fractions
were frozen with solid CO2 immediately. The total eluate for each
fraction (∼ 30 ml) was later thawed and concentrated to 1–3 ml
using an ultrafiltration membrane with molecular-mass cut-off of
30 kDa. After adding 30 ml of 50 mM ammonium bicarbonate,
the samples were then concentrated to within 15 ml (to further
remove the solvent and non-volatile salt from the samples) and
then freeze-dried.
ThT (thioflavin T) binding

MATERIALS AND METHODS
Materials

Bovine milk κ-CN (Swiss-Prot accession number P02668),
without the N-terminal 21-amino-acid leader peptide, was
purchased from Sigma Chemical Co. Protease inhibitors tablets
(EDTA-free) were obtained from Roche, DTT (1,4-dithiothreitol)
was obtained from Astral Scientific and uranyl acetate was
purchased from Agar Scientific. All other reagents were obtained
from Sigma and were of analytical grade, and all solutions
were prepared with ultrapure milliQ water. The concentration
of κ-CN was determined using a Cary 5000 UV–visible–nearIR spectrophotometer (Varian) and an absorption coefficient of
0.95 ml · mg−1 · cm−1 at 280 nm [28].
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The formation of amyloid fibrils by multimeric RCMκ-CN and
its components was monitored using a conventional ThT assay, as
described previously [18,30]. Protein solutions were prepared at
3 mg/ml in 50 mM sodium phosphate buffer (pH 7.0) containing
2 mM EDTA. Fibril formation was induced by incubating protein
solutions either with 40 mM DTT at 37 ◦C, or without DTT at
37 or 60 ◦C. Aliquots (3 × 10 μl) were periodically withdrawn
from protein solutions during their incubation, and then snap
frozen at −20 ◦C. Freezing had no noticeable affect on fibril
morphology. At the completion of the time course, each sample
was thawed and then mixed with 1.6 ml of 10 μM ThT in 50 mM
glycine buffer, raised to pH 9.0 with NaOH. The fluorescence
was then measured using a glass cuvette (10 mm light path) and
a Cary Eclipse spectrofluorimeter (Varian) with the excitation
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and emission wavelengths set at 442 and 490 nm respectively, as
described previously [18,30]. The results shown are averages of
triplicate readings.

In situ ThT and light-scattering assays

The formation of amyloid fibrils by DTT-reduced κ-CN and
RCMκ-CN was monitored using an in situ ThT binding or by
a light-scattering assay as described previously [7,31]. Briefly,
the protein was incubated at 37 ◦C in 50 mM sodium phosphate
buffer (pH 7.2), with 20 mM DTT added to the solution in assays
using native κ-CN. For the ThT assays, samples were incubated
with 50 μM ThT at concentrations of 0.25–15 mg/ml. Owing to
the decreased sensitivity of the light-scattering assay, data could
only be collected for protein concentrations of 0.5–15 mg/ml. In
each assay, the initial reaction rate was taken as the slope of the
linear line-of-best-fit to either the ThT or light-scattering data over
the first 180 min.

Figure 1

Determination of the CMC of RCMκ-CN

The CMC was determined as the intersection point of the line-of-best-fit for the initial portion of
the curve where the surface tension shows a linear decline with increasing protein concentration
and the baseline of minimal surface tension at the higher concentrations of protein, i.e.
0.54 +
− 0.05 mg/ml.

RESULTS
Reduced κ-CN forms fibrils at concentrations below its CMC

SDS/PAGE analysis

Gel electrophoresis was performed on 12 % (v/v) acrylamide gels
using the method of Laemmli [32]. Samples were loaded without
prior heating or reduction. Gels were stained with Coomassie
Blue R-250. Densitometry was performed using ImageJ software
(NIH) to estimate the proportion of each species in each sample.

Molecular mass measurements by SEC

The oligomer size distribution of κ-CN fractions under various
conditions was assessed by SEC using a Superdex-200 HR 10/30
column. Proteins (0.15 mg) were injected in 100 μl volumes, and
eluted at a flow rate of 0.5 ml/min. The column was calibrated with
the following molecular-mass standards (Sigma): Blue Dextran
(2000 kDa), thyroglobulin (669 kDa), apoferritin (443 kDa),
β-amylase (206 kDa), ovotransferrin (76 kDa), ovalbumin
(45 kDa), carbonic anhydrase (29 kDa), myoglobin (17 kDa)
and dimeric insulin (12 kDa). Molecular-mass standards were
prepared and eluted with 50 mM sodium phosphate buffer and
2 mM EDTA (pH 7.0).

MALLS (multi-angle laser light scattering)

The weighted-average molecular mass of oligomeric species
eluting from the Superdex-200 HR 10/30 column was determined
by MALLS. Multimeric RCMκ-CN at 10 mg/ml was separated
by SEC at a flow rate of 0.25 ml/min, and the elution of the
protein monitored by a miniDAWNTM TREOS triple-angle light
scattering detector coupled with an Optilab rEx refractive index
and UV light detector (Wyatt Technology). Data analyses were
performed using Astra (Wyatt Technology).

TEM (transmission electron microscopy)

Samples for TEM were prepared by adding 2 μl of protein
solution to formvar- and carbon-coated nickel grids (SPI
Supplies). The grids were then washed three times with 10 μl
of water and negatively stained with 10 μl of 2 % (w/v) uranyl
acetate (Agar Scientific). The grids were dried with filter paper
between each step. The samples were viewed under 25 000–64 000
magnifications at 80 kV excitation voltages using a Philips CM100
transmission electron microscope.

The micelle-like behaviour of RCMκ-CN at high concentrations
results in an equilibrium between oligomeric and dissociated
forms of the protein [25]. To determine the effective CMC of
RCMκ-CN, i.e. the concentration below which the protein does
not form micelle-like species, we measured changes in surface
tension with increasing concentrations of protein. We determined
the CMC for RCMκ-CN (Figure 1) and DTT-reduced κ-CN
(results not shown) to be 0.54 +
− 0.05 and 0.46 +
− 0.06 mg/ml
+
respectively (i.e. 29 +
2.6
and
24
−
− 3.2 μM). This is in close
agreement with the CMC reported previously for reduced κ-CN
(0.53 mg/ml, i.e. 28 μM) [25]. Thus, at concentrations below
∼ 0.5 mg/ml (i.e. 26 μM), no micelle-like forms of RCMκ-CN
or DTT-reduced κ-CN are present in solution.
We then investigated whether fibrils were formed at
concentrations below the CMC. At concentrations of 0.1 and
0.2 mg/ml, we observed increases in ThT fluorescence indicative
of fibril formation by RCMκ-CN and DTT-reduced κ-CN (see
below). We examined these samples for the presence of fibrils
by TEM. At 0.1 mg/ml, short unbranched fibrils were present,
typical of those formed by RCMκ-CN that we have described
previously [18,31] (Figure 2A). When RCMκ-CN was incubated
at concentrations above its CMC (i.e. >0.5 mg/ml), the protein
formed fibrils of the same overall morphology (Figure 2B). We
found similar results when we examined samples of DTT-reduced
κ-CN incubated at concentrations above and below its CMC,
i.e. fibrils were formed with overall morphology similar to those
described above.
The rate of κ-CN fibril formation is affected by its oligomeric state

We had reported previously that the initial rate of increase in
ThT fluorescence associated with RCMκ-CN fibril formation
was first-order with respect to protein concentration from 0.1 to
10 mg/ml (see Figure 1C of [7]). We performed further analysis
of the kinetics of fibril formation by RCMκ-CN (Figure 3)
and κ-CN reduced with DTT (results not shown) using higher
protein concentrations (up to 15 mg/ml). The results show that, at
concentrations below or close to the CMC (i.e. <0.5 mg/ml),
the initial rate of increase (over the first 180 min) of ThT
fluorescence (Figure 3A) and light scattering (Figure 3B) is
linear with respect to RCMκ-CN concentration. However, as the
protein concentration increases above the CMC, the initial rates
approaches a maximum rate. These results suggest that, as the
protein oligomerizes through non-covalent interactions to form
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Figure 2
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Transmission electron micrographs of fibrils formed by RCMκ-CN at concentrations below (A) and above (B) its CMC

RCMκ-CN was incubated at 0.1 mg/ml (A) and 1.0 mg/ml (B). Scale bars, 200 nm.

Figure 3 Rate of fibril formation of RCMκ-CN as monitored by ThT
fluorescence (A) and light scattering at 340 nm (B)
For both (A) and (B), the initial reaction rate at each concentration was determined from the
increase in the ThT fluorescence or light scattering data over the first 180 min of incubation.
AU, absorbance units.

a micelle-like species, it is stabilized and its propensity to form
fibrils decreases.
Isolating various multimeric fractions of partially reduced
RCMκ-CN

A fraction of κ-CN that was more abundant in dissociated
disulfide-linked species (e.g. dimer and trimer) was prepared
by only partially reducing the protein, followed by
carboxymethylation. First, peptide species that make up only a
small proportion of the total sample were removed from native
κ-CN via ultrafiltration. The resulting κ-CN sample (>100 kDa)
was more extensively disulfide-linked than native κ-CN as judged
by SDS/PAGE (results not shown), and subsequent reduction
and carboxymethylation via standard methods yielded a mixture
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of disulfide-linked multimers with a unique size distribution,
which we term ‘multimeric’ RCMκ-CN. Native κ-CN comprises
a near-uniform distribution of multimers, with monomers to
decamers each comprising approx. 10 % of the total protein [23].
Multimeric RCMκ-CN, however, comprised 23 % monomer,
23 % dimer and 13 % trimer, with the remainder encompassing a
range of larger multimers (see below, Figures 5B and 5C).
From this multimeric RCMκ-CN sample, we endeavoured to
isolate individual species and examine their propensity to form
fibrils. A number of commonly used dissociating agents were
investigated for their ability to disrupt the higher-order association
inherent to native and multimeric RCMκ-CN (Figure 4). Native
κ-CN eluted from the size-exclusion column as a broad peak
centred at 7 ml, characteristic of the highly associated micellelike state (Figure 4A). Addition of the dissociating agents SDS
(2 %, w/v), urea (8 M) and ACN (33 %, v/v) all decreased the
amount of micelle-like species and resulted in lower-molecularmass species being produced. ACN was the most effective
at disrupting the higher-order non-covalent oligomerization of
native κ-CN, producing peaks with retention volumes of 10 and
15 ml. Multimeric RCMκ-CN eluted from the column as a broad
peak centred at 8 ml and a smaller peak at 13 ml corresponding
to its micelle-like and dissociated forms respectively (Figure 4B).
Again, each of the dissociating agents disrupted the higher-order
association of multimeric RCMκ-CN, with ACN (33 %, v/v)
being the most effective. ACN caused the majority of the protein
to elute in peaks with retention volumes between 10 and 15 ml
and left very little of the protein remaining in the micelle-like
state.
We therefore exploited the ability of ACN to disrupt the
micelle-like nature of RCMκ-CN in order to separate the protein
via SEC into various fractions of differing molecular mass
(Figure 5A). Analysis of the peaks obtained from the column
by non-reducing SDS/PAGE and quantitative densitometry of the
resultant bands on the gel indicated that Fraction 1 (collected
between 9.8 and 11.3 ml) consisted predominately of multimeric
species with molecular masses of ∼ 60 and ∼ 80 kDa, as well as a
large number of higher-molecular-mass species (i.e. >∼ 200 kDa)
(Figures 5B and 5C). On the basis of a mass of 19 kDa for
the monomeric form of the protein, these species correspond to
trimers, tetramers and larger multimers respectively. Fraction 2
(collected between 11.3 and 12.8 ml) consisted predominately
of dimeric and trimeric species, whereas fraction 3 (collected
between 12.8 and 14.3 ml) comprised mostly monomeric species.
Fraction 3 therefore closely resembled the fully reduced form of
the protein (Figures 5B and 5C). The minor band observed at
25 kDa in a number of κ-CN preparations most likely comprised

Dissociated κ-casein forms fibrils
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Dissociation of native κ-CN and multimeric RCMκ-CN

Elution profiles of native untreated κ-CN (A) and multimeric RCMκ-CN (B) separated by SEC.
Proteins were eluted with either 50 mM sodium phosphate (pH 7.2) (——) or 50 mM ammonium
acetate (pH 7.2) with one of three dissociating agents, i.e. 2 % (w/v) SDS (– · · – · · ), 33 %
(v/v) ACN ( – –) or 8 M urea ( · · · · · ), on a Superdex-200 HR 10/30 column at a flow rate
of 0.5 ml/min. Molecular-mass calibrant standards (in kDa) are indicated by 䉲. a.u., arbitrary
units.

a mixture of the other caseins (i.e. α s1 -, α s2 - and β-casein) present
in milk and are referred to as ‘other’.
The oligomerization and fibril-forming propensity of multimeric
RCMκ-CN fractions

Fractions 1–3, obtained under dissociating conditions (see
above), were subsequently analysed by SEC under nondissociating conditions in order to establish a relationship
between their higher-order oligomerization (arising from noncovalent interactions) and their propensity for fibril formation
(Figure 6). Each of the fractions eluted in various proportions in three discrete peaks centred at 7.0, 11.6 and 13.6 ml,
and designated high- (HMW), moderate- (MMW) and low(LMW) molecular-mass respectively. As expected, there was a
strong correlation between the degree of intermolecular disulfide
bonding and the overall degree of oligomerization. For instance,
native κ-CN and fraction 1, which each comprised between 50
and 67 % higher-order multimers (i.e. >tetramer) (Figures 5B

Figure 5

Fractionation of multimeric RCMκ-CN

(A) Elution profile of multimeric RCMκ-CN separated by SEC. Proteins were eluted with 50 mM
ammonium acetate and 30 % (v/v) ACN (pH 7.2) on a Superdex-200 HR 10/30 column at a flow
rate of 0.5 ml/min. (B) SDS/PAGE analysis under non-reducing conditions of, from left to right,
native untreated κ-CN, multimeric RCMκ-CN, fractions 1, 2 and 3, obtained from separation
of multimeric RCMκ-CN by SEC, and fully reduced RCMκ-CN. Molecular-mass markers are
shown on the right-hand side of the gel and the position of bands in the gel assigned as
monomer, dimer, trimer and tetramer are given on the left-hand side of the gel. (C) Percentage
of disulfide-linked multimers in fractions of native and RCMκ-CN obtained by densitometric
analysis of Coomassie Blue-stained protein separated by SDS/PAGE. ‘Other’ represents the
proportion of protein that could not be ascribed to either monomer or dimer, corresponding to
a molecular mass of ∼ 25 kDa. a.u., arbitrary units.

and 5C), assembled almost entirely into HMW oligomers
(Figures 6A and 6B). Conversely, fully reduced RCMκ-CN
and fraction 3, which each comprised approx. 60 % monomer
(Figures 5B and 5C), remained essentially dissociated in the
absence of ACN, with 15 % or less of the protein assembling
into HMW species (Figures 6A and 6B). Interestingly,
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Figure 6
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Higher-order oligomerization of RCMκ-CN fractions

(A) Elution profiles of native, untreated κ-CN (–––), multimeric RCMκ-CN (— —), fractions
1 (– – –), 2 (- - - -), and 3 ( · · · · · · ) of multimeric RCMκ-CN obtained by SEC, and
fully reduced RCMκ-CN (– · – · –). Proteins (1.5 mg/ml) were eluted with 50 mM sodium
phosphate (pH 7.2) on a Superdex-200 HR 10/30 column at a flow rate of 0.5 ml/min.
Molecular-mass calibrant standards (in kDa) are indicated by 䉲. (B) Percentage of LMW,
MMW and HMW species in fractions of native κ-CN and RCMκ-CN based on SEC elution
profiles in (A). (C) Weighted-average molecular mass of LMW and HMW species upon SEC
elution of multimeric RCMκ-CN, as assessed by MALLS. a.u., arbitrary units.

fraction 2, characterized by an abundance of dimeric and
trimeric disulfide-linked species (Figures 5B and 5C), formed
instead a significant population (∼ 40 %) of an intermediate
(MMW) oligomeric species (Figures 6A and 6B). The remainder
of fraction 2 formed mostly HMW species, with very little
LMW species. MALLS measurements of multimeric RCMκ-CN
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Figure 7

Fibril-forming propensity of native κ-CN and RCMκ-CN fractions

(A) ThT fluorescence analysis of native κ-CN, multimeric RCMκ-CN, fractions (1–3) of
multimeric RCMκ-CN obtained from SEC and fully reduced RCMκ-CN, incubated for 2 days
at 37 ◦C (black) and 60 ◦C (dark grey) under non-reducing conditions, and at 37 ◦C in the
presence of 40 mM DTT (light grey). Results shown are means +
− S.E.M. obtained from triplicate
measurements and are representative of three experiments. a.u., arbitrary units. (B) Electron
micrographs depict native (N) κ-CN, and fractions 1, 2 and 3 of multimeric RCMκ-CN obtained
by SEC, following 2 days of incubation under non-reducing conditions at 37 ◦C and 60 ◦C.
Scale bars, 500 nm.

showed that these HMW species varied greatly in terms of
their molecular mass (Figure 6C), which, despite an average
mass of 760 kDa (i.e. a 40-mer based on a monomeric mass of
19 kDa), ranged from 450 to 6000 kDa. The dissociated LMW
species, however, were much less polydisperse with a molecular
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Table 1 Correlation between κ-CN species present in a sample with its
fibril-forming propensity
Multimer indicates a species greater than a tetramer. The percentage of species was obtained
by densitometric analysis of SDS/PAGE bands as shown in Figures 5(B) and 5(C). Correlation
coefficients were produced by plotting the percentage of species in each fraction against the
log10 of the increase in ThT fluorescence at 37 ◦C without DTT shown in Figure 7(A).

Figure 8 Correlation of the proportion of monomer and higher-order
multimers present in a κ-CN sample with the sample’s fibril-forming
propensity
The percentage of monomeric species (䉲) or species larger than tetramer (䊉), in each sample,
was obtained by densitometric analysis of bands present in a SDS/PAGE gel (as shown in
Figures 5B and 5C). This is plotted against the log10 of the increase in ThT fluorescence
obtained from incubation of the sample at 37 ◦C without DTT (as shown in Figure 7A).

mass range of 45–130 kDa and an average mass of 62 kDa (i.e. a
trimer).
The ability of these fractions to form fibrils was examined
by ThT fluorescence under non-reducing conditions at 37 and
60 ◦C, and under reducing conditions at 37 ◦C (Figure 7A). As
the extent of oligomerization increased (in terms of both the
number of subunits in the disulfide-linked multimers and their
subsequent propensity to form higher-order species via noncovalent interactions), the extent of fibril formation decreased.
For example, fraction 1, an ensemble of predominately trimeric,
tetrameric and larger disulfide-linked multimers that associated
into HMW species (Figures 5 and 6), had the lowest propensity
for fibril formation (Figure 7A). In contrast, fraction 3, which
comprised a high degree of monomeric species that most closely
resembled the fully reduced state of the protein, showed the
biggest increase in ThT fluorescence indicative of fibril formation.
Moreover, this increase in ThT fluorescence was not enhanced by
reduction and mirrored that of the fully reduced protein. Upon
addition of DTT, however, all of the fractions were found to
have a similar increase in ThT fluorescence, indicating that the
differences between the fractions are mediated by their disulfidebonding patterns, which, in turn, governs their higher-order
association.
These findings were verified by TEM (Figure 7B), which
showed a progressive increase from fractions 1 to 3 in the
length and apparent number of fibrils formed at 37 ◦C. Again,
the differences between fractions were much less apparent upon
addition of DTT (results not shown) or upon raising the incubation
temperature to 60 ◦C. Thus each of the fractions, including native
κ-CN, has the capacity to form fibrils, but their propensity to do so
is restrained by their propensity for non-fibrillar oligomerization.
To illustrate this further, the extent of fibril formation by each
fraction at 37 ◦C in the absence of DTT, as indicated by their ThT
fluorescence increase, was plotted against the percentage of each
of their disulfide-linked components (monomer to higher-order
multimer).
As shown in Figure 8 and Table 1, there is a strong relationship
(R=0.85) between the percentage of monomer present in the

Species

R value

Mixture

R value

Multimer
Tetramer
Trimer
Dimer
Monomer

−0.98
−0.13
−0.02
0.55
0.85

Tetramer and less
Trimer and less
Dimer and less

0.93
0.97
0.98

sample (obtained from the values measured in Figures 5B and
5C) and its fibril-forming propensity (obtained from the increase
in ThT fluorescence shown in Figure 7A). Moreover, there is also
a very strong negative correlation (Figure 8, R=−0.98) between
the proportion of higher-order multimers (i.e. species more than
a tetramer) present in the sample (Figures 5B and 5C) and its
propensity for fibril formation (Figure 7). The correlation between
the percentage of dimer in the samples and fibril formation was
weaker (R = 0.55). However, when the amount of monomer, dimer
and trimer in the samples was correlated with the propensity of the
sample to form fibrils, there was a very strong relationship (dimer
and less, R=0.98; trimer and less, R=0.97) Thus the monomeric
form of κ-CN appears to be the most amyloidogenic species,
although the dimer and trimer, the predominant species in fraction
2 (Figure 5B), clearly have some propensity for fibril formation
(Figures 7A and 7B).
DISCUSSION

Bovine milk κ-CN has an inherent propensity to form amyloid
fibrils when incubated under conditions of physiological pH and
temperature in vitro, the rate of which is enhanced by reduction
of its disulfide bonds [18,26]. Reduction does not lead to any
significant changes in the secondary or tertiary structure of
κ-CN [26] and therefore the increased propensity of the reduced
protein to form fibrils is largely mediated through changes to
its quaternary structure. The ability of κ-CN to form oligomers,
through covalent disulfide bonds and non-covalent interactions,
leads to a heterogeneous population of species in solution, which
is complicated further by the strong dependence of the association
state of the protein on factors such as concentration, pH, temperature, method of purification and extent of reduction [26]. Thus,
in the present study, we have differentiated between oligomeric
micelle-like states (formed via non-covalent interactions) and
dissociated states (consisting of monomers, dimers, trimers, etc.,
whereby the oligomers arise from disulfide bonds). We have
shown that RCMκ-CN and DTT-reduced κ-CN are capable of
forming fibrils at concentrations below their CMC, i.e. at concentrations at which only dissociated forms of the protein are present.
At concentrations below or close to the CMC (i.e. <0.5 mg/ml) the
initial reaction rate is linear and first-order with respect to protein
concentration [7]. Moreover, we show that the propensity of κ-CN
to forms fibrils is inversely correlated with its initial oligomerization state. Together, these data provide further support for our
proposed model of fibril formation by κ-CN in which dissociated
forms are the amyloidogenic precursor to fibril formation [7].
Whereas our current and previous data [7] indicate that
dissociated forms of κ-CN are the precursor to fibril formation,
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it was proposed recently that a conformational change to the
micelle-like state of RCMκ-CN is prerequisite to it forming fibrils
and that the micelle-like state is therefore the amyloidogenic
precursor [27]. This proposal was based on the following
observations: (i) RCMκ-CN adopts a micelle-like form before
fibril formation, as observed by TEM; (ii) the diameter of the
fibrils is the same as the diameter of the oligomeric micelle-like
species (i.e. 10–12 nm); (iii) there is a change in the intermolecular
β-strands of the protein in the fibrillar state compared with
the native micelle-like state as determined by FTIR (Fouriertransform IR) spectroscopy; and (iv) the rate constant of fibril
formation reaches a plateau at high protein concentrations. Our
results show clearly that RCMκ-CN and DTT-reduced κ-CN are
both capable of forming fibrils at concentrations at which micellelike forms of the protein are not present. Furthermore, we show
that oligomerization stabilizes and prevents fibril formation by
κ-CN. In its native state, above its CMC, reduced κ-CN exists in
equilibrium between micelle-like species and dissociated forms
[25,33]. Whereas the diameter of these oligomers is similar to
that of the fibrils formed by the protein (i.e. 10–15 nm), it is wellestablished that the diameter of fibrils in general is in this range
(∼ 10 nm) [34], and, as such, this is likely a coincidence rather
than evidence for the micelle-like state being the amyloidogenic
precursor.
Our previous findings indicated that, upon fibril assembly,
κ-CN undergoes structural rearrangement within the protein,
particularly to the region that we have shown forms the proteaseresistant β-sheet core of the fibrils (i.e. Tyr25 –Lys86 ) [7]. It
is unsurprising that fibril assembly involves alterations in the
intermolecular β-sheet arrangement between protein monomers,
since, in the native state, these intermolecular interactions
facilitate micelle formation, whereas in the fibril, they are
responsible for β-sheet stacking along the long axis of the fibril.
Thus we propose that this β-sheet rearrangement accounts for
the structural changes between RCMκ-CN before and after fibril
formation that were observed previously by us [7] and by Leonil
et al. [27]. Moreover, the FTIR data do not necessarily indicate
that conformational rearrangement occurs within the micellelike species itself to enable fibril formation, rather, that the
intermolecular β-sheet arrangement in micellar native RCMκCN differs from that present in the fibrillar form of the protein.
When the initial rate of ThT fluorescence (Figure 3A)
and light scattering (Figure 3B) is plotted against RCMκCN concentration, our data show that it follows a relationship
whereby, at concentrations below or close to the CMC, it is linear
and first-order with respect to RCMκ-CN concentration [7,27],
but at high concentrations, the rate reaches a plateau (i.e. the
reaction is zero-order with respect to RCMκ-CN concentration).
The first-order relationship at concentrations below or close
to the CMC support our model in which dissociated forms
of RCMκ-CN are responsible for fibril formation [7,27], as
addition of protein would lead to a direct increase in the amount
of amyloidogenic precursor available for fibril formation, thus
increasing the reaction rate proportionally. The reaction rate
reaching a plateau at concentrations well above the CMC can
be rationalized by considering the effect of concentration on the
association state of RCMκ-CN in solution. Above the CMC, the
amount of dissociated species in solution increases proportionally
until reaching a point at which the stability of the micellelike state is maximal and the concentration of the dissociated
species becomes independent of the total protein concentration
[25,33]. Thus, under our proposed model [7,27], at high RCMκCN concentrations, the rate of fibril formation would become
zero-order with respect to the total protein concentration, as was
found to be the case in the present study. In contrast, if the
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amyloidogenic precursor were the micelle-like state of RCMκCN [27], then the reaction rate would be first-order with respect
to protein concentration at all concentrations above the CMC.
Our previously proposed model predicts that factors which
enhance the amount or rate of dissociation of κ-CN from its
micelle-like state will increase the rate of fibril formation [7].
Reduction and heat are two such factors which most likely
enhance the rate of fibril formation through such mechanisms
and are consistent with ours and other studies [7,18,26]. Leonil
et al. [27] also indicated that glycosylation decreases the rate of
fibril formation by inhibiting dissociation. Therefore the increased
rate of fibril formation by non-glycosylated RCMκ-CN (which
has an increased rate of dissociation [27]) is accounted for in our
model [7]. In the casein micelle, the amount of the dissociated
amyloidogenic species is very low because of the interaction of
κ-CN with the other casein proteins (i.e. α S - and β-casein), both
of which are effective inhibitors of κ-CN fibril formation in a
chaperone-like manner [18,35].
The present study highlights the role of the intermolecular
disulfide bonds to stabilize further the oligomeric micellar form
of κ-CN and thus protect the protein against fibril formation. We
have shown previously that native κ-CN, although extensively
disulfide-linked, forms fibrils when subjected to temperatures
of 37 ◦C or higher [18]. Our present findings indicate that the
observed fibrils originate from dissociated monomeric, dimeric
and trimeric species. This is significant in the light of our recent
findings that α s2 -casein, a milk protein closely related to κCN, readily assembles into amyloid fibrils from a disulfidelinked dimer ([30] and D.C. Thorn, T. Kouldelka, H. Ecroyd,
M. Sunde and J.A. Carver, unpublished work). Proteins that
are natively associated are generally thought to revert to a
monomeric intermediate state before fibril formation proceeds.
This dissociation event is invariably induced by altering the
solution or environmental conditions, and generally accompanies
a variety of additional changes in the secondary and tertiary
structure of the protein. For example, fibril formation by insulin
or transthyretin is readily induced at 37 ◦C by acidic pH,
causing denaturation and concomitant monomer formation [8,36].
Disulfide reduction of native oligomeric κ-CN, however, appears
not to accompany significant changes in secondary or tertiary
structure [26]. Thus, by regulating the chain of disulfide linkages
in κ-CN, we have unambiguously shown how the amyloid-fibrilforming pathway may be progressively overcome by alternative
aggregation pathways, e.g. native oligomerization.
We suggest that such a process of inhibition is far more
significant than presently recognized, playing a broader role in
the prevention of fibril formation by disease-related proteins. In
particular, models of fibril formation in which the rate-limiting
step is the dissociation of an amyloidogenic precursor [7], rather
than formation of stable nuclei, may be more applicable to
disease-related proteins such as transthyretin (dissociation from
a multisubunit complex) or the amyloid β-peptides (formed by
proteolytic cleavage). With regard to transthyretin, it is now wellestablished that the dissociation of monomer from its tetrameric
state is the rate-limiting step in its fibril formation [8,37,38].
Accordingly, small molecules that stabilize the multimeric state of
transthyretin (e.g. benzoxazoles) are effective inhibitors of fibril
formation under both physiological and denaturing conditions
[39], and are in current development as therapeutic agents for the
treatment of familial amyloid polyneuropathy and other diseases
associated with transthyretin fibril formation [40]. These smallmolecule inhibitors bind to unoccupied thyroxine-binding sites
and thus appear to mimic protein stabilization normally mediated
by its natural ligand [41]. Similarly, κ-CN is stabilized and
fibril formation is prevented by other casein proteins, its natural
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binding partners [18]. The crucial difference, however, between
transthyretin and κ-CN is that transthyretin is a well-structured
protein and fibril formation follows a pathway of partial unfolding
and consequential dissociation, whereas κ-CN is unstructured and
the amyloidogenic form of the protein is structurally analogous
to its native state, albeit dissociated (i.e. fibril formation does
not require partial unfolding). Whether small molecules could
stabilize the micelle-like state of κ-CN and thereby limit fibril
formation by this protein is therefore unclear.
In conclusion, our results indicate that dissociated forms of
κ-CN are the amyloidogenic precursors to its fibril formation.
The monomeric form has the highest propensity for fibril
formation, although disulfide-linked dimeric and trimeric forms
also retain some fibril-forming propensity. Moreover, higherorder oligomerization of κ-CN inhibits fibril formation. Thus
interactions involving κ-CN, either with itself or with other
casein proteins, are not only essential for the formation of the
casein micelle (and therefore the nutritional qualities of milk),
but are also important in preventing the accumulation of amyloid
deposits in mammary tissue which would otherwise be favoured
by the reducing environment of the epithelial cells that are
responsible for casein synthesis and secretion. Although the
vast majority of research to date has been aimed at developing
strategies to reduce oligomerization/aggregation in general by
disease-associated proteins, the present study also highlights the
potential for the design of therapeutics that stabilize multimeric
amyloidogenic proteins as a means of preventing fibril formation,
as has been suggested for transthyretin [40,42].
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